{
  "age": 69,
  "gender": {
    "category": "Male",
    "intersex_condition": null
  },
  "weight": {
    "weight_kg": 81,
    "height_cm": 176,
    "bmi_category": "Overweight"
  },
  "ethnicity": "Hispanic/Latino",
  "disease": {
    "name": "Lung Cancer",
    "diagnosed_years_ago": 1,
    "prognosis": "Stable"
  },
  "comorbidities": [],
  "treatments": [
    {
      "treatment_name": "Pembrolizumab (IV)",
      "dosage_mg_per_day": 160,
      "percent_week_administered": 14,
      "indication": "Primary"
    }
  ],
  "genetic_variants": [
    {
      "gene": "PD-L1",
      "variant": "Tumour proportion score >=50%",
      "effect": "High PD-L1 expression â€” predictor of response to anti-PD-1 therapy"
    }
  ]
}











